vyvanse and tirzepatide U.S. allows ADHD drugmaker to increase production limit to ease shortage Tirzepatide vs Semaglutide for Weight

The projected growth of this market is another encouraging indicator

The results from the phase III STEP (Semaglutide treatment effect in people with obesity) clinical programme have shown that semaglutide provides clinically meaningful and sustained weight loss in ranges much higher than those achieved with previously available pharmacotherapies

ZZ: Conceptualization, Funding acquisition, Writing original draft, Writing review & editing

About 37% of Americans have a family member or friend who is taking a GLP-1 for weight loss or for a chronic condition, per KFF

doi: 10.1007/s42000-019-00118-4 [DOI] [PubMed] [Google Scholar] 94